Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma

被引:55
作者
Domingues, R
Mendonça, E
Sobrinho, L
Bugalho, MJ
机构
[1] Ctr Reg Oncol Lisboa, Inst Portugues Oncol Francisco Gentil, CIPM, P-1099023 Lisbon, Portugal
[2] Ctr Reg Oncol Lisboa, Inst Portugues Oncol Francisco Gentil, Dept Patol Morfol, P-1099023 Lisbon, Portugal
[3] Ctr Reg Oncol Lisboa, Inst Portugues Oncol Francisco Gentil, Serv Endocrinol, P-1099023 Lisbon, Portugal
关键词
fine needle aspiration cytology; RET rearrangements; papillary thyroid carcinoma; BRAF mutation;
D O I
10.1111/j.1365-2303.2004.00223.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: Searching for multiple molecular markers in thyroid aspirates appears to be a promising approach for establishing a preoperative diagnosis of papillary thyroid carcinoma (PTC). Methods: Based on this hypothesis, a total of 63 samples from 55 patients, were collected at random. RNA was extracted from the residue cells inside the needle used for fine needle aspiration cytology (FNAC) and thereafter molecular analysis was carried out both for RET rearrangements (type 1, 2, 3) and BRAF codon 599 mutation molecule. Results were compared with the cytological and histopathological diagnoses in 24 patients submitted to surgery. Results: 58% PTCs presented a genetic alteration either RET/PTC rearrangement, BRAF V599E mutation or both: three cases of PTCs (25%) presented a RET/PTC rearrangement; three cases of PTCs (25%) presented a BRAF V599E mutation and in one case (8%) both alterations were identified. Conclusions: The present results suggest that searching for multiple molecular markers in thyroid aspirates may enhance the accuracy of FNAC and refine preoperative diagnosis of PTC.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 28 条
[11]   Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules [J].
Goldstein, RE ;
Netterville, JL ;
Burkey, B ;
Johnson, JE .
ANNALS OF SURGERY, 2002, 235 (05) :656-662
[12]  
Kimura ET, 2003, CANCER RES, V63, P1454
[13]  
Klugbauer S, 1995, ONCOGENE, V11, P2459
[14]   Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions [J].
Kolch, W .
BIOCHEMICAL JOURNAL, 2000, 351 :289-305
[15]  
Ludwig L, 2001, CANCER RES, V61, P4526
[16]   THYROID-CANCER IN THYROID-NODULES - FINDING A NEEDLE IN THE HAYSTACK [J].
MAZZAFERRI, EL .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (04) :359-362
[17]  
Nikiforov YE, 1997, CANCER RES, V57, P1690
[18]   RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors:: Evidence for distinct molecular pathways in thyroid follicular carcinoma [J].
Nikiforova, MN ;
Lynch, RA ;
Biddinger, PW ;
Alexander, EK ;
Dorn, GW ;
Tallini, G ;
Kroll, TG ;
Nikiforov, YE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (05) :2318-2326
[19]   BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas [J].
Nikiforova, MN ;
Kimura, ET ;
Gandhi, M ;
Biddinger, PW ;
Knauf, JA ;
Basolo, F ;
Zhu, ZW ;
Giannini, R ;
Salvatore, G ;
Fusco, A ;
Santoro, M ;
Fagin, JA ;
Nikiforov, YE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5399-5404
[20]  
Rebelo S, 2003, INT J ONCOL, V23, P1025